Skip to content

Randomised trial, 2018

How do progesterone metabolites affect PMDD symptoms?

Women with PMDD respond differently to these natural brain chemicals. Blocking one type may reduce negative mood symptoms, but this summary is incomplete.

Early or limited evidence Multiple studies reviewed

What they did

This is a summary of existing research about how progesterone metabolites (especially allopregnanolone) affect PMDD. It discusses lab studies, brain imaging findings, and clinical trials of related medications.

What they found

Women with PMDD show altered sensitivity to allopregnanolone, a metabolite of progesterone. Brain imaging shows increased emotional reactivity in the amygdala (emotion center) during the luteal phase in women with PMDD. A medication called isoallopregnanolone significantly reduced negative mood symptoms when given by injection during the premenstrual phase in a randomized controlled trial.

What it means for you

PMDD appears to involve abnormal brain responses to natural progesterone metabolites. Blocking these metabolites may help mood symptoms. However, this is a summary of existing research, not a new study, so the quality and strength of evidence varies. The original abstract provided is incomplete, making it difficult to assess all the findings.

3-5%

Percentage of women with PMDD

allopregnanolone

Progesterone metabolite studied

UC1010

Blocking medication tested

About the study

Original title
Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder
Authors
Bixo M, Johansson M, Timby E et al.
Journal
Journal of neuroendocrinology
Year
2018
Study design
Randomised trial
What was tested
Discussion of how progesterone metabolites and blocking medications affect PMDD
Open access
Yes

Topics